General Principles - The company establishes an external guarantee management system to ensure the protection of investors' rights and the safety of company assets [1][2] - External guarantees refer to the company providing guarantees for the debts of others, excluding guarantees for its own debts [1][2] Approval Process for External Guarantees - External guarantee matters must be approved by the company's board of directors or shareholders' meeting [4][5] - The board must investigate the financial and operational status of the guaranteed party before making a decision [5][6] - Certain external guarantees require submission to the shareholders' meeting for approval, including guarantees exceeding 10% of the company's latest audited net assets [6][7] Management of Guarantee Contracts - Approved guarantee projects must be formalized in written contracts that comply with relevant laws and regulations [14][15] - The company must manage guarantee contracts and related documents diligently, ensuring their completeness and accuracy [15][16] - The finance department is responsible for monitoring the financial status of the guaranteed party and reporting to the board [16][17] Disclosure Obligations - The company must disclose information about external guarantees in a timely manner, including details about the guarantee situation and any overdue guarantees [21][22] - Confidentiality measures must be taken to limit the number of individuals aware of guarantee information before it is publicly disclosed [22][23] Accountability Mechanism - The board of directors is responsible for interpreting the guarantee management system [29] - Individuals who sign guarantee contracts without proper authorization may be held liable for any resulting losses to the company [24][25] - Directors who violate laws or regulations in the guarantee decision-making process may face joint liability for losses incurred [26][27]

Core Viewpoint - The core purpose of market value management is to align the company's market value with its intrinsic value by focusing on core business, enhancing operational efficiency, and improving core competitiveness [1][3]. Group 1: Objectives and Principles of Market Value Management - The primary objective of market value management is to enhance the company's value creation capability through effective information disclosure and investor relations management [1]. - The basic principles of market value management include compliance, systematic approach, scientific methods, normalization, and proactivity [4][2]. Group 2: Organizational Structure and Responsibilities - The board of directors leads the market value management efforts, with the chairman as the primary responsible person and the board secretary overseeing specific tasks [6]. - The board is responsible for establishing an internal control system for market value management, focusing on improving company quality and considering investor interests in major decisions [6]. Group 3: Main Methods of Market Value Management - Key methods for promoting the company's investment value include mergers and acquisitions, equity incentives, cash dividends, investor relations management, information disclosure, and share buybacks [7][6]. - The company should focus on its core business and improve operational efficiency while utilizing various methods to reflect the company's quality in its investment value [7][6]. Group 4: Monitoring and Early Warning Mechanism - The securities department is responsible for monitoring market value indicators and setting reasonable warning thresholds to analyze and report any significant changes [7]. - In the event of a significant or continuous decline in stock price, the company should take timely measures to analyze the reasons, communicate with investors, and potentially implement share buybacks or cash dividends [7].

Core Points - The company, Anhui Huaren Health Pharmaceutical Co., Ltd., was established to protect the rights and interests of shareholders, employees, and creditors, and to regulate its organization and behavior according to relevant laws [3][4] - The company was registered with a capital of RMB 400.01 million and is a permanent corporation [4][5] - The company issued 60.01 million shares to the public and was listed on the Shenzhen Stock Exchange on March 1, 2023 [3][4] Chapter Summaries General Provisions - The company is established in accordance with the Company Law and other relevant regulations [3] - The legal representative of the company is the chairman, who is responsible for civil activities conducted in the company's name [4][5] - The company operates under the principle of "quality first, integrity-based" [4][5] Business Objectives and Scope - The registered name of the company is Anhui Huaren Health Pharmaceutical Co., Ltd., with its address in Hefei City [4] - The business scope includes drug wholesale, food sales, medical device sales, and various consulting services [4][5] Shares - The company has issued a total of 40.01 million shares, all of which are ordinary shares [6] - The company can provide financial assistance for others to acquire its shares, with a limit of 10% of the total issued capital [6][7] Shareholder and Shareholder Meeting - Shareholders have rights to dividends, attend meetings, and supervise the company's operations [16][19] - The company must hold an annual general meeting within six months after the end of the previous fiscal year [26][27] - Shareholders holding more than 10% of shares can request a temporary meeting [29][30] Voting and Resolutions - Resolutions can be ordinary or special, requiring a majority or two-thirds majority of the voting rights, respectively [79] - The company must ensure that the meeting records are accurate and preserved for at least ten years [41]

General Overview - The document outlines the working rules for the Secretary of the Board of Anhui Huaren Health Pharmaceutical Co., Ltd, aiming to improve corporate governance and clarify the rights, obligations, and responsibilities of the board secretary [1][2]. Responsibilities of the Board Secretary - The board secretary is responsible for handling information disclosure, managing investor relations, and coordinating communication between the company and various stakeholders [6][7]. - The board secretary must ensure the timely, accurate, complete, and lawful disclosure of information [2][3]. - The board secretary is tasked with organizing board and shareholder meetings, maintaining meeting records, and ensuring compliance with relevant laws and regulations [6][7]. Qualifications for the Board Secretary - The board secretary must possess necessary financial, management, and legal knowledge, and must adhere to high ethical standards [4][5]. - Individuals with certain disqualifying conditions, such as recent administrative penalties or market bans, are prohibited from serving as board secretary [4][5]. Appointment and Dismissal Procedures - The board secretary is appointed by the board for a term of three years, which aligns with the board's term [4][5]. - Dismissal of the board secretary requires sufficient justification, and the company must report the reasons for dismissal to the Shenzhen Stock Exchange [4][5]. Additional Provisions - The company must provide necessary conditions for the board secretary to perform their duties effectively [6][7]. - In the event of a vacancy, the board must appoint an interim secretary and complete the appointment of a new secretary within a specified timeframe [7][8].

安徽华人健康医药股份有限公司 内幕信息知情人登记管理制度 第一章 总则 董事会秘书具体负责公司内幕信息的日常管理工作，证券部是公司信息 披露管理、投资者关系管理、内幕信息登记备案的日常办事机构。 公司审计委员会对内幕信息知情人登记管理制度实施情况进行监督。 第二章 内幕信息及内幕信息知情人的范围 第六条 本制度所指内幕信息是指根据《证券法》相关规定，涉及公司的经营、 财务或者对公司股票、证券及其衍生品种交易价格有重大影响的尚未公 开的信息。包括但不限于： （一）公司的经营方针和经营范围的重大变化； （二）公司的重大投资行为，公司在一年内购买、出售重大资产超过公 司资产总额百分之三十，或者公司营业用主要资产的抵押、质押、出售 或者报废一次超过该资产的百分之三十； （三）公司订立重要合同、提供重大担保或者从事关联交易，可能对公 司的资产、负债、权益和经营成果产生重要影响； （四）公司发生重大债务和未能清偿到期债务的违约情况； （五）公司发生重大亏损或者重大损失； （六）公司生产经营的外部条件发生的重大变化； （七）公司的董事、或者总裁发生变动，董事长或者总裁无法履行职责； （八）持有公司百分之五以上股份的股东或者 ...

安徽华人健康医药股份有限公司 第六条 投资者关系工作的目的是： 第七条 投资者关系工作的基本原则是： 投资者关系管理制度 第一章 总则 1 第一条 为进一步完善安徽华人健康医药股份有限公司（以下简称"公司"）治 理结构，规范公司投资者关系工作，加强公司与投资者和潜在投资者（以 下统称"投资者"）之间的沟通，加深投资者对公司的了解和认同，促 进公司和投资者之间长期、稳定的良好关系，提升公司的诚信度、核心 竞争能力和持续发展能力，实现公司价值最大化和股东利益最大化，根 据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司投资者关 系管理工作指引》《深圳证券交易所创业板股票上市规则》（以下简称 "《股票上市规则》"）、《深圳证券交易所上市公司自律监管指引第2 号——创业板上市公司规范运作》等法律、法规、规范性文件及公司章 程的规定，结合公司实际情况，制定本制度。 第二条 投资者关系管理是指公司通过便利股东权利行使、信息披露、互动交流 和诉求处理等工作，加强与投资者及潜在投资者之间的沟通，增进投资 者对上市公司的了解和认同，以提升公司治理水平和企业整体 ...

安徽华人健康医药股份有限公司 董事会议事规则 第一章 总则 该董事对公司商业秘密保密的义务在其任职结束后仍然有效，直至 该秘密成为公开信息。其他义务的持续期间应当根据公平的原则决 定，视事件发生与离任之间时间的长短，以及与公司的关系在何种 情况和条件下结束而定。 第二章 董事会的组成和职权 第一条 为规范安徽华人健康医药股份有限公司（以下简称"公司"）董事会 的决策行为和运作程序，保证公司决策行为的民主化、科学化，建 立适应现代市场经济规律和要求的公司治理机制，完善公司的法人 治理结构，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》《深圳证券交易所上市公司创业板股票上 市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板 上市公司规范运作》等法律、法规，以及《安徽华人健康医药股份 有限公司章程》（以下简称"公司章程"）的有关规定，特制订本规则。 第二条 公司设董事会，董事会由股东会选举产生。董事会是公司经营管理 的决策机构，维护公司和全体股东的利益，在公司章程的规定和股 东会的授权范围内，负责公司发展目标和重大经营活动的决策，对 股东会负责并向股东会报告工作。 ...

安徽华人健康医药股份有限公司 董事和高级管理人员所持本公司股份 及其变动管理制度 第一章 总则 （二）新任董事在股东会（或者职工代表大会）通过其任职事项后两 个交易日内； （三）新任高级管理人员在董事会通过其任职事项后两个交易日内； （四）现任董事、高级管理人员在其已申报的个人信息发生变化后的 两个交易日内； （五）现任董事、高级管理人员在离任后两个交易日内； 第二章 买卖公司股份行为的申报 第一条 为加强对安徽华人健康医药股份有限公司（以下简称"公司"或"本公 司"）董事和高级管理人员所持本公司股份及其变动的管理，进一步 明确相关办理程序，根据《中华人民共和国公司法》（以下简称"《公 司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《深圳证券交易所创业板股票上市规则》、《深圳证券交易所上市 公司自律监管指引第 2 号——创业板上市公司规范运作》、《上市 公司董事和高级管理人员所持本公司股份及其变动管理规则》等相 关法律、法规、规范性文件以及《公司章程》等有关规定，特制定 本制度。 第二条 本制度中董事和高级管理人员所持本公司股份是指登记在其名下的 所有本公司股份；从事融资融券交易的，还包括 ...

证券代码：301408 证券简称：华人健康 公告编号：2025-047 安徽华人健康医药股份有限公司 第五届董事会第十次会议决议公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 2.01 《关于修订<股东大会议事规则>的议案》 安徽华人健康医药股份有限公司（以下简称"公司"）第五届董事会第十次 会议已于 2025 年 6 月 26 日以书面、邮件送达形式发出通知，并于 2025 年 6 月 30 日在公司 6 楼 601 会议室以现场结合通讯的方式举行，本次会议应到董事 9 名，实到董事 9 名，其中董事鲁勖、殷俊、刘亮、程谋以通讯表决方式出席。本 次会议由公司董事长何家乐先生召集和主持，公司监事和高级管理人员列席了会 议。本次会议的召集和召开符合相关法律法规及《公司章程》的规定，做出的决 议合法有效。 二、董事会会议审议情况 本次会议审议并通过如下议案： 1、审议通过《关于修订<公司章程>的议案》 根据《中华人民共和国公司法》《关于新<公司法>配套制度规则实施相关过 渡期安排》《上市公司章程指引》等相关法律法规的规定，公司将不再设 ...

安徽华人健康医药股份有限公司 会计师事务所选聘制度 第一章 总则 会计师事务所的审计费用由股东会决定。 第四条 公司控股股东、实际控制人不得向公司指定会计师事务所，不得干 预审计委员会独立履行审核职责。 第二章 会计师事务所执业质量要求 1 第一条 为了规范安徽华人健康医药股份有限公司（以下简称"公司"）选聘 （含变更）会计师事务所行为，切实维护公司及股东利益，根据 《中华人民共和国公司法》《中华人民共和国证券法》（以下简称 "《证券法》"）《国有企业、上市公司选聘会计师事务所管理办法》 《上市公司治理准则》《深圳证券交易所创业板股票上市规则》等 相关法律、行政法规、部门规章、规范性文件及《安徽华人健康医 药股份有限公司章程》（以下简称"《公司章程》"）的相关规定，结 合公司实际，特制定本制度。 第二条 本制度所称选聘会计师事务所，是指公司聘用符合《证券法》规定 的会计师事务所进行会计报表审计、净资产验证及其他相关的咨询 服务等业务。 第三条 公司聘用、解聘会计师事务所，由股东会决定。董事会不得在股东 会决定前委任会计师事务所。 第五条 公司选聘的会计师事务所应当具备下列条件： （一）具有独立的主体资格，具备 ...